TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Evodiamine, Gemcitabine
Phytochemical Name Evodiamine (PubChem CID: 442088 )
Anticancer drug Name Gemcitabine (PubChem CID: 60750 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 21
Pair Name Evodiamine, Gemcitabine
Disease Info [ICD-11: 2B62.Z] Tongue cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Down-regulation Expression BCL2 hsa596
Down-regulation Expression BCL-xL hsa598
Down-regulation Expression RELA hsa5970
In Vitro Model CAL-27 Tongue adenosquamous carcinoma Homo sapiens (Human) CVCL_1107
Tca8113 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_6851
In Vivo Model CAL-27 cells (2×10⁶) were injected subcutaneously into the right armpit regions of nude mice.
Result The results of this study showed that EVO may inhibit cancer cells by suppressing NF-κB activity, and in combination with GEM, it may increase the chemosensitivity of tongue squamous cancer cells, thereby improving the treatment response.
03. Reference
No. Title Href
1 Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo. Onco Targets Ther. 2018;12:257-267. Published 2018 Dec 27. doi:10.2147/OTT.S181062 Click
It has been 26370 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP